Skip to main content
. Author manuscript; available in PMC: 2019 Nov 29.
Published in final edited form as: Neuropharmacology. 2018 Jul 5;139:85–97. doi: 10.1016/j.neuropharm.2018.07.002

Fig. 2. PrNMI dose-dependently suppresses cisplatin-induced mechanical (A) and cold allodynia (B) in male rats.

Fig. 2.

PrNMI is administered by intraperitoneal injection. Data points are fit by least squares non-linear regression to estimate ED50 values (n = 6–7 rats).